176 related articles for article (PubMed ID: 37506247)
1.
Wang L; Jiang C; Hu D
Aging (Albany NY); 2023 Jul; 15(14):6757-6773. PubMed ID: 37506247
[TBL] [Abstract][Full Text] [Related]
2. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
3. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
4. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
6. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
7. High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Qin T; Zhao H; Shao Y; Hu N; Shi J; Fu L; Zhang Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32519744
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
9. [The Prognostic Value of FOSB Gene in Acute Myeloid Leukemia].
Luan SH; Ma YQ; Yang JJ; Wang H; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1063-1070. PubMed ID: 35981363
[TBL] [Abstract][Full Text] [Related]
10. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome.
Jiang G; Capo-Chichi JM; Liu A; Atenafu EG; Guo R; Tierens A; Minden MD; Chang H
Hum Pathol; 2020 Oct; 104():117-126. PubMed ID: 32798550
[TBL] [Abstract][Full Text] [Related]
12.
Han Q; Zhang Q; Song H; Bamme Y; Song C; Ge Z
Front Oncol; 2020; 10():149. PubMed ID: 32175272
[TBL] [Abstract][Full Text] [Related]
13. CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly acute myeloid leukemia patients.
Guo L; Chen L; Wang H
Cancer Biomark; 2018; 23(3):455-463. PubMed ID: 30347598
[TBL] [Abstract][Full Text] [Related]
14. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
Yan Y; Li X; Gao J
J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
[TBL] [Abstract][Full Text] [Related]
15. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
18. Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy.
Tang H; Chen Y; Zhang N; Deng J; Zhou K
Ann Hematol; 2023 Dec; 102(12):3401-3412. PubMed ID: 37878012
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.
Cui L; Cheng Z; Liu Y; Dai Y; Pang Y; Jiao Y; Ke X; Cui W; Zhang Q; Shi J; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):15-21. PubMed ID: 30578412
[TBL] [Abstract][Full Text] [Related]
20. High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects.
Li X; Li C; Jin J; Wang J; Huang J; Ma Z; Huang X; He X; Zhou Y; Xu Y; Yu M; Huang S; Yan X; Li F; Pan J; Wang Y; Yu Y; Jin J
EBioMedicine; 2018 Dec; 38():47-56. PubMed ID: 30472087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
